Both in Pharmaceuticals
Aquestive Therapeutics vs Tilray Brands
Over the past year AQST returned −17.3% and TLRY returned −78.6%; their daily moves had a correlation of 0.09.
AQST −17.3% TLRY −78.6%Growth of $1, one year, split-adjusted
| Metric | AQST | TLRY |
|---|---|---|
| Price | $4.67 | $3.95 |
| Market cap | $586.1M | $583.7M |
| Today | −1.68% | −1.74% |
| 1 month | −7.0% | −13.9% |
| 6 months | +15.6% | −34.1% |
| Year to date | −27.7% | −56.3% |
| 1 year | −22.0% | −65.7% |
| Revenue growth (YoY) | +38.1% | +25.5% |
| Gross margin | 70.9% | 32.1% |
| Net margin | −165.5% | −17.6% |
| P/E (TTM) | — | — |
| Price / sales | 10.8× | 0.6× |
| Net cash | $47.8M | $83.9M |
| Dividend yield | — | — |
| Volatility (60d) | 48.4% | 46.2% |
| Short % of float | 25.2% | 14.4% |
| Next earnings | — | Oct 8, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).